SUBSCRIBE
SUBSCRIBE
BioCapital

FDA Pleads for More Research on Anemia Drugs

January 7, 2010 | 
1 min read

MedPage Today -- FDA officials used the pages of the New England Journal of Medicine to call for more studies of erythropoiesis-stimulating agents (ESAs) in an effort to improve their safe use.

Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Pictured: Man holding tablet computer with scienti
Job Trends
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
June 6, 2024
 · 
3 min read
 · 
Greg Slabodkin
Pictured: FDA sign at its office in Washington, DC/iStock, JHVEPhoto
Policy
FDA Again Rejects Supernus Drug-Device Combo for Parkinson’s Disease
April 8, 2024
 · 
2 min read
 · 
Tyler Patchen
Pictured: 3d illustration of hepatitis B viruses i
Drug Development
Altimmune Axes Hepatitis B Program After Phase II Failure, Focuses on Obesity and MASH
March 28, 2024
 · 
1 min read
 · 
Tyler Patchen